US2016089471A1PendingUtilityA1
Sheet for cutaneous application containing vitamin e or an ester thereof
Est. expiryMay 6, 2033(~6.8 yrs left)· nominal 20-yr term from priority
Inventors:Giorgio Panin
A61L 15/26A61K 31/355A61L 2300/606A61L 2300/428A61L 15/44A61L 2420/06A61L 2420/02
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein the layer of silicone elastomer has a thickness less than or equal to 2.0 mm and the silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C 8 -C 18 fatty acids.
Claims
exact text as granted — not AI-modified1 . A sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein said layer of silicone elastomer has a thickness less than or equal to 2.0 mm and said silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C 8 -C 18 fatty acids.
2 . The sheet according to claim 1 , wherein said loosely woven fabric is gauze.
3 . The sheet according to claim 1 , wherein said silicone elastomer incorporates an ester of vitamin E with a carboxylic acid of formula R—COOH, wherein R is an alkyl radical having 1 to 19 carbon atoms, or an alkenyl or alkynyl radical having 2 to 19 carbon atoms.
4 . The sheet according to claim 3 , wherein said ester of vitamin E is vitamin E acetate, n-propionate or linoleate.
5 . The sheet according to claim 4 , wherein said ester of vitamin E is alpha-tocopheryl acetate.
6 . The sheet according to claim 1 , wherein said vitamin E or ester thereof is contained in said layer of silicone elastomer in an amount of between 2% and 40%.
7 . The sheet according to claim 1 , wherein said vitamin E or ester thereof is contained in said layer of silicone elastomer in an amount of between 5% and 30%, by weight of the weight of the silicone elastomer.
8 . The sheet according to claim 1 , wherein said triglyceride of saturated C 8 -C 18 fatty acids is contained in an amount of 1-3% by weight of the weight of the silicone elastomer.
9 . The sheet according to claim 1 , wherein said triglyceride of saturated C 8 -C 18 fatty acids is selected from the group consisting of Caprylic/Capric Triglyceride, Caprylic/Capric/Stearic Triglyceride and Caprylic/Capric/Myristic/Stearic Triglyceride.
10 . The sheet according to claim 8 , wherein said triglyceride of saturated C 8 -C 18 fatty acids is Caprylic/Capric Triglyceride.
11 . The sheet according to claim 1 , wherein said layer of silicone elastomer has a thickness of between 0.2 and 1.5 mm.
12 . The sheet according to claim 1 , wherein said silicone elastomer is a vinyl-substituted polysiloxane crosslinked with a polyalkyl hydrosiloxane.
13 . The sheet according to claim 12 , wherein said silicone elastomer is a Bis-Vinyl Dimethicone/Dimethicone Copolymer (INCI nomenclature).
14 . (canceled)
15 . A process for the production of a sheet for cutaneous application comprising a support layer made of loosely woven fabric embedded in a layer of silicone elastomer incorporating vitamin E or an ester thereof, wherein said layer of silicone elastomer has a thickness less than or equal to 2.0 mm, said silicone elastomer contains an elasticity modifier consisting of a triglyceride of saturated C8-C18 fatty acids, and said silicone elastomer is a vinyl-substituted polysiloxane crosslinked with a polyalkyl-hydrosiloxane, which process comprises the steps of:
a) dispersing at room temperature and while stirring the vitamin E or its ester and the triglyceride of saturated C8-C18 fatty acids in a vinyl-substituted polysiloxane, in an amount equal to 3.8-84.4% and 2.9-21.1% by weight of the vinyl-substituted polysiloxane, b) adding, again while stirring, a polyalkyl hydrosiloxane in a weight ratio with respect to the vinyl-substituted polysiloxane ranging from 0.9:1.0 to 1.1:1.0, obtaining a homogeneous dispersion; c) depositing on the support layer made of loosely woven fabric said homogeneous dispersion in a layer with a thickness of 0.2-2.0 mm and leaving it at room temperature for a time sufficient to obtain the formation of the sheet.
16 . The process according to claim 15 , wherein said vinyl-substituted polysiloxane is Bis-Vinyl Dimethicone and said polyalkylhydrosiloxane is Hydrogen-Dimethicone (INCI nomenclature).
17 . The process according to claim 15 , wherein in said step a) vitamin E acetate is dispersed in said vinyl-substituted polysiloxane in an amount of between 7.5-45% by weight of the weight of the vinyl-substituted polysiloxane.
18 . The process according to claim 15 , wherein said support layer made of loosely woven fabric is a cotton gauze.
19 - 22 . (canceled)
23 . The sheet according to claim 2 , wherein said gauze is a cotton gauze.
24 . A method for preventing the formation of keloids and abnormal wound healing processes and for the treatment of already formed keloids in a skin area of a subject, comprising the application of a the sheet according to claim 1 to said skin area.
25 . A method for treating sunburn in a skin area of a subject, comprising the application of the sheet according to claim 1 to said skin area.
26 . A method for relaxing and moisturizing a skin area of a subject, comprising the application of the sheet according to claim 1 to said skin area.Join the waitlist — get patent alerts
Track US2016089471A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.